vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
36.52
+1.11 (3.13%)
At close: Mar 9, 2026, 4:00 PM EDT
35.79
-0.73 (-2.00%)
After-hours: Mar 9, 2026, 5:54 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $453.17 million as of March 9, 2026. Its market cap has increased by 337.92% in one year.
Market Cap
453.17M
Enterprise Value
355.03M
1-Year Change
337.92%
Ranking
Category
Stock Price
$36.52
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $453.17M, an increase of 480.06%. That is a compound annual growth rate of 18.03%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 462.75M |
| Altimmune | 460.45M |
| Century Therapeutics | 459.90M |
| Entrada Therapeutics | 452.88M |
| Lineage Cell Therapeutics | 448.31M |
| Assembly Biosciences | 447.15M |
| REGENXBIO | 446.45M |
| Tenax Therapeutics | 433.70M |